{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T04:02:20Z","timestamp":1781755340111,"version":"3.54.5"},"reference-count":28,"publisher":"Elsevier BV","issue":"46","license":[{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Sciences Foundation of China","doi-asserted-by":"crossref","award":["31272562"],"award-info":[{"award-number":["31272562"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1016\/j.vaccine.2015.09.069","type":"journal-article","created":{"date-parts":[[2015,10,2]],"date-time":"2015-10-02T07:48:05Z","timestamp":1443772085000},"page":"6268-6276","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Assessment of a novel recombinant vesicular stomatitis virus with triple mutations in its matrix protein as a vaccine for pigs"],"prefix":"10.1016","volume":"33","author":[{"given":"Xinkui","family":"Fang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yufang","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinchu","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shikuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2015.09.069_bib0145","first-page":"1364","article-title":"Rhabdoviridae","volume":"1","author":"Lyles","year":"2007"},{"issue":"5","key":"10.1016\/j.vaccine.2015.09.069_bib0150","doi-asserted-by":"crossref","first-page":"556","DOI":"10.2460\/javma.1997.211.05.556","article-title":"Review of the 1995 vesicular stomatitis outbreak in the western United States","volume":"211","author":"Bridges","year":"1997","journal-title":"J Am Vet Med Assoc"},{"issue":"1","key":"10.1016\/j.vaccine.2015.09.069_bib0155","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/nrmicro2240","article-title":"Viruses as vaccine vectors for infectious diseases and cancer","volume":"8","author":"Draper","year":"2010","journal-title":"Nat Rev Microbiol"},{"issue":"5","key":"10.1016\/j.vaccine.2015.09.069_bib0160","doi-asserted-by":"crossref","first-page":"3723","DOI":"10.1128\/JVI.73.5.3723-3732.1999","article-title":"Attenuated vesicular stomatitis viruses as vaccine vectors","volume":"73","author":"Roberts","year":"1999","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2015.09.069_bib0165","first-page":"165","article-title":"Recombinant rhabdoviruses: vectors for vaccine development and gene therapy","volume":"292","author":"Finke","year":"2005","journal-title":"Curr Top Microbiol Immunol"},{"issue":"14","key":"10.1016\/j.vaccine.2015.09.069_bib0170","doi-asserted-by":"crossref","first-page":"8039","DOI":"10.1128\/JVI.77.14.8039-8047.2003","article-title":"Vesicular stomatitis virus glycoprotein is a determinant of pathogenesis in swine, a natural host","volume":"77","author":"Martinez","year":"2003","journal-title":"J Virol"},{"issue":"4","key":"10.1016\/j.vaccine.2015.09.069_bib0175","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1128\/JVI.73.4.2921-2929.1999","article-title":"A proline-rich motif within the matrix protein of vesicular stomatitis virus and rabies virus interacts with WW domains of cellular proteins: implications for viral budding","volume":"73","author":"Harty","year":"1999","journal-title":"J Virol"},{"issue":"9","key":"10.1016\/j.vaccine.2015.09.069_bib0180","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1099\/vir.0.83096-0","article-title":"Modifications of the PSAP region of the matrix protein lead to attenuation of vesicular stomatitis virus in vitro and in vivo","volume":"88","author":"Irie","year":"2007","journal-title":"J Gen Virol"},{"issue":"4","key":"10.1016\/j.vaccine.2015.09.069_bib0185","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S1535-6108(03)00241-1","article-title":"VSV strains with defects in their ability to shutdown innate immunity are potent systemic anti-cancer agents","volume":"4","author":"Stojdl","year":"2003","journal-title":"Cancer Cell"},{"issue":"7","key":"10.1016\/j.vaccine.2015.09.069_bib0190","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1016\/j.vaccine.2011.12.085","article-title":"Evaluation of attenuated VSVs with mutated M or\/and G proteins as vaccine vectors","volume":"30","author":"Fang","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.09.069_bib0195","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.molcel.2004.11.023","article-title":"VSV disrupts the Rae1\/mrnp41 mRNA nuclear export pathway","volume":"17","author":"Faria","year":"2005","journal-title":"Mol Cell"},{"key":"10.1016\/j.vaccine.2015.09.069_bib0200","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1017\/S0967199406003716","article-title":"In vitro developmental competence of pig nuclear transferred embryos: effects of GFP transfection, refrigeration, cell cycle-synchronization and shapes of donor cells","volume":"14","author":"Zhang","year":"2006","journal-title":"Zygote"},{"issue":"21","key":"10.1016\/j.vaccine.2015.09.069_bib0205","doi-asserted-by":"crossref","first-page":"11359","DOI":"10.1073\/pnas.93.21.11359","article-title":"Foreign glycoproteins expressed from recombinant vesicular stomatitis viruses are incorporated efficiently into virus particles","volume":"93","author":"Schnell","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"10.1016\/j.vaccine.2015.09.069_bib0210","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/sj.cgt.7700794","article-title":"Systemic therapy of experimental breast cancer metastases by mutant vesicular stomatitis virus in immune-competent mice","volume":"12","author":"Ebert","year":"2005","journal-title":"Cancer Gene Ther"},{"issue":"10","key":"10.1016\/j.vaccine.2015.09.069_bib0215","doi-asserted-by":"crossref","first-page":"4477","DOI":"10.1073\/pnas.92.10.4477","article-title":"Recombinant vesicular stomatitis viruses from DNA","volume":"92","author":"Lawson","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"10.1016\/j.vaccine.2015.09.069_bib0220","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1006\/viro.1998.9508","article-title":"Influenza A virus lacking the NS1 gene replicates in interferon-deficient systems","volume":"252","author":"Garcia-Sastre","year":"1998","journal-title":"Virology"},{"issue":"11","key":"10.1016\/j.vaccine.2015.09.069_bib0225","doi-asserted-by":"crossref","first-page":"2782","DOI":"10.1099\/vir.0.023978-0","article-title":"Fusion-active glycoprotein G mediates the cytotoxicity of vesicular stomatitis virus M mutants lacking host shut-off activity","volume":"91","author":"Hoffmann","year":"2010","journal-title":"J Gen Virol"},{"issue":"13","key":"10.1016\/j.vaccine.2015.09.069_bib0230","doi-asserted-by":"crossref","first-page":"6107","DOI":"10.1128\/JVI.75.13.6107-6114.2001","article-title":"Rearrangement of the genes of vesicular stomatitis virus eliminates clinical disease in the natural host: new strategy for vaccine development","volume":"75","author":"Flanagan","year":"2001","journal-title":"J Virol"},{"issue":"17","key":"10.1016\/j.vaccine.2015.09.069_bib0235","doi-asserted-by":"crossref","first-page":"9311","DOI":"10.1128\/JVI.00722-12","article-title":"Foot-and-mouth disease virus 3C protease cleaves NEMO to impair innate immune signaling","volume":"86","author":"Wang","year":"2012","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.vaccine.2015.09.069_bib0240","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1002\/jmv.20506","article-title":"Rapid and simple detection of IFN-neutralizing antibodies in chronic hepatitis C non-responsive to IFN-alpha","volume":"78","author":"Jorns","year":"2006","journal-title":"J Med Virol"},{"issue":"4","key":"10.1016\/j.vaccine.2015.09.069_bib0245","doi-asserted-by":"crossref","first-page":"516","DOI":"10.2460\/ajvr.2001.62.516","article-title":"Contact transmission of vesicular stomatitis virus New Jersey in pigs","volume":"62","author":"Stallknecht","year":"2001","journal-title":"Am J Vet Res"},{"issue":"1","key":"10.1016\/j.vaccine.2015.09.069_bib0250","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S1535-6108(03)00330-1","article-title":"Defective translational control facilitates vesicular stomatitis virus oncolysis","volume":"5","author":"Balachandran","year":"2004","journal-title":"Cancer Cell"},{"issue":"9","key":"10.1016\/j.vaccine.2015.09.069_bib0255","doi-asserted-by":"crossref","first-page":"5524","DOI":"10.1128\/JVI.77.9.5524-5528.2003","article-title":"The cell-rounding activity of the vesicular stomatitis virus matrix protein is due to the induction of cell death","volume":"77","author":"Kopecky","year":"2003","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2015.09.069_bib0260","doi-asserted-by":"crossref","first-page":"4646","DOI":"10.1128\/JVI.77.8.4646-4657.2003","article-title":"Ability of the matrix protein of vesicular stomatitis virus to suppress beta interferon gene expression is genetically correlated with the inhibition of host RNA and protein synthesis","volume":"77","author":"Ahmed","year":"2003","journal-title":"J Virol"},{"issue":"12","key":"10.1016\/j.vaccine.2015.09.069_bib0265","doi-asserted-by":"crossref","first-page":"4506","DOI":"10.1158\/0008-5472.CAN-08-0238","article-title":"Oncolytic vesicular stomatitis viruses are potent agents for intravesical treatment of high-risk bladder cancer","volume":"68","author":"Hadaschik","year":"2008","journal-title":"Cancer Res"},{"issue":"17","key":"10.1016\/j.vaccine.2015.09.069_bib0270","doi-asserted-by":"crossref","first-page":"9522","DOI":"10.1128\/JVI.77.17.9522-9532.2003","article-title":"Newcastle disease virus V protein is a determinant of host range restriction","volume":"77","author":"Park","year":"2003","journal-title":"J Virol"},{"issue":"5\u20136","key":"10.1016\/j.vaccine.2015.09.069_bib0275","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.cytogfr.2007.06.006","article-title":"Innate immune evasion by hepatitis C virus and West Nile virus","volume":"18","author":"Keller","year":"2007","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.vaccine.2015.09.069_bib0280","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1099\/vir.0.2008\/004606-0","article-title":"The multifunctional NS1 protein of influenza A viruses","volume":"89","author":"Hale","year":"2008","journal-title":"J Gen Virol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X15013456?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X15013456?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,11]],"date-time":"2024-06-11T14:33:24Z","timestamp":1718116404000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X15013456"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11]]},"references-count":28,"journal-issue":{"issue":"46","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["S0264410X15013456"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.09.069","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessment of a novel recombinant vesicular stomatitis virus with triple mutations in its matrix protein as a vaccine for pigs","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.09.069","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}